MedTrace Logo

Effect of Methylphenidate on Ecologic Function in Paediatric Acquired Brain Injury Population

NCT02227056 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2019-02-26

No results posted yet for this study

Summary

The purpose of this study is to investigate the influence of Methylphenidate in pediatric acquired brain injury population, regarding ecologic (every day) function. It is hypothesized that the function with treatment will improve when compared to function without treatment in the same patient. Improvement is expected by shortening time of execution in each specific task and by reduction of the amount of assistance needed.

Conditions

  • Acquired Brain Injury

Interventions

DRUG

Methylphenidate

On three different days each participant will receive Methylphenidate in a dosage of 0.3 milligram/kilo rounded to the nearest full milligram dosage

Sponsors & Collaborators

  • Loewenstein Hospital

    lead OTHER

Principal Investigators

  • Sharon Shaklai, Dr · Loewenstein Hospital Rehabilitation Center

  • Sigal Greenbaum, Master · Loewenstein Hospital Rehabiltation Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-01-30
Completion
2017-03-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02227056 on ClinicalTrials.gov